TCS, in our study, exhibited an increased percentage in the CD8+ CD45RA+ CD57+ cells (41.6% (22.2–55.6) vs 24.7% (10.1–32.2) p = 0.015) compared to controls. This evidence concerns the gene CD8A and Treacher-Collins syndrome.